✦ LIBER ✦

Association between CYP3A enzyme activity and ciprofloxacin and clarithromycin pharmacokinetics in patients with cystic fibrosis

✍ Scribed by X. Nielsen; K. Dalhoff; A. Jensen; G. Jürgens; C.R. Hansen; U. Johansen; T. Pressler; N. Høiby

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic variability of clarithro

✍ Dalbøge, C.S.; Nielsen, X.C.; Dalhoff, K.; Alffenaar, J.W.; Duno, M.; Buchard, A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 254 KB

78 Pharmacokinetic variability of clarit

✍ Dalbøge, C.S.; Nielsen, X.C.; Dalhoff, K.; Alffenaar, J.-W.; Duno, M.; Buchard, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

106 Pharmacokinetic variability of clari

✍ C.S. Dalbøge; X.C. Nielsen; K. Dalhoff; M. Dunø; A. Buchara; J.-W.C. Alffenaar; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Pharmacokinetics and antibacterial activ

✍ P. Bruinenberg; B. Otulana; J. Blanchard; D. Cipolla; J. Wilson; D. Serisier 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 59 KB

385 Cutaneous phototoxicity secondary to

✍ J.P. Tolland; J. Boyle; J. Rendall; R.J. Davies; K.E. McKenna; J.S. Elborn 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Tolerability and Pharmacokinetic Propert

✍ Stass, Heino; Weimann, Boris; Nagelschmitz, Johannes; Rolinck-Werninghaus, Claud 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 276 KB